Ignite Creation Date:
2024-05-06 @ 12:20 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01557660
Status:
WITHDRAWN
Last Update Posted:
2012-03-26
First Post:
2012-03-14
Brief Title:
Inhaled Treprostinil for PAH Open-label Extension
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Study Overview
Official Title:
Inhaled Treprostinil in Subjects With Pulmonary Arterial Hypertension An Open-Label Phase III International Multi-Center Study
Status:
WITHDRAWN
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INTREPID - OL
Brief Summary:
Open-label extension of RIN-PH-302
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None